Trial NCT02447887

View at ClinicalTrials.gov 
Org. Study IDs: GU-071
Secondary IDs: 14-052

Last trial update was posted on 2019-09-26

MeSH Interventions

Interferon alpha-2 Ixazomib

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Metastatic Renal Cell Carcinoma RCC

Stopping Reasons

IRB study closure facilitated by Investigator

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID